What's in Alberta Health services's pipeline?

Alberta Health services has 4 drugs in our index: 2 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Alberta Health services's portfolio?

Top competitors by shared drug class: Asahi Kasei Pharma Corporation, Assistance Publique - Hôpitaux de Paris, Astellas Pharma China, Inc., Baxter, BeBetter Med Inc.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/alberta-health-services.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Alberta Health services — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Alberta Health services pipeline: 2 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 1 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
strontium-89	strontium-89	marketed	Radiopharmaceutical; bone-seeking radioisotope	Hydroxyapatite in bone matrix; osteoblast uptake	Oncology
Salagen	Salagen	marketed		Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3	Cardiovascular
intravenous busulfan	intravenous busulfan	phase 3	Alkylating agent		Oncology

Therapeutic area mix

Oncology · 2
Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Asahi Kasei Pharma Corporation · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Astellas Pharma China, Inc. · 1 shared drug class
Baxter · 1 shared drug class
BeBetter Med Inc · 1 shared drug class
Celyad Oncology SA · 1 shared drug class
Children's Cancer Group, China · 1 shared drug class
Al-Azhar University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Alberta Health services:

Cite this brief

Drug Landscape (2026). Alberta Health services — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/alberta-health-services. Accessed 2026-05-17.